News

Clariness announces that it has achieved a consistent patient reachability of over 90%, globally, since the deployment of AI-powered, ClinLife® Connect. The newfound patient reachability is the result of integrating a new patient contact module into ClinLife®, which was developed using Silicon Valley founded state-of-the-art tech, and...

Odyssey Health, Inc., a company focused on developing life-enhancing medical products, has selected Syneos Health, a biopharmaceutical services organization to support its Investigational New Drug (IND) Application. Odyssey Health is developing a pharmaceutical treatment for mild Traumatic Brain Injury...

Myricx Bio, a UK biotech company focused on the discovery and development of a completely novel class of antibody-drug conjugate (ADC) payloads based on N-Myristoyltransferase inhibition (NMTi), and WuXi Biologics (“WuXi Bio”) (2269.HK), a leading global Contract Research, Development...

Chiesi Farmaceutici S.p.A, an international, research-focused biopharmaceuticals and healthcare group, and Haisco Pharmaceutical Group Co. Ltd entered a licensing agreement to develop, manufacture, and commercialize outside China and adjacent territories (Hong Kong SAR, Macau SAR, and Taiwan District) HSK31858,...

Cryoport, Inc., a leading global provider of innovative products and services to the fast-growing cell and gene therapy industry enabling the future of medicine for a new era of life sciences announced the expansion of its global supply chain...

The advancements in technology and the desire for minimally invasive surgeries have converged to propel the field of robotic urological surgeries to the forefront. As the healthcare landscape evolves, robotics' importance is becoming increasingly evident, particularly within the urological sphere....

The market when it comes to connected drug delivery devices is going through rapid growth, with an expected annual market growth rate of more than 20% between 2023 and 2030. This progress is driven, in part, by the increasing...